http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-002028-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
filingDate 1996-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b8da15cb46070c90888624c01694db4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c75c029d3c6971955ec6ad158625c34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3aa2370b4aae68e2e9f998c9bee0a02a
publicationDate 1998-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-002028-A1
titleOfInvention SUBSTITUTED BIPHENYL SULPHONAMIDES, ENDOTHELINE ANTAGONIST, AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
abstract Compounds of formula (I) are described, which inhibit the activity of 1 endothelin. The symbols are defined as follows: R1 and R2 are each attached to a carbon ring and are each independently; (a) hydrogen; (b) alkyl or alkoxy; (c) hydroxyl; (d) halo; or (e) amino; R3 and R4 are both directly attached to a carbon ring and are each independently (a) hydrogen; (b) alkyl, alkene, alkyne, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkene, cycloalkenoalkyl, aryl, aryloxy, aralkyl or aralkoxy, any of which can be substituted by Z1, Z2 and Z3; (c) halo; (d) hydroxyl; (e) cyano; (f) nitro; (g) -C (O) H or -C (O) R5; (h) -CO2H or -CO2R5; (i) -Z4-NR6R7; (j) -Z4-N (R10) -Z5-NR8R9; Or (k) R3 and R4 together may also be alkylene or alkenylene, either of which may be substituted with Z1, Z2, Z3 completing a saturated, unsaturated 4- to 8-membered aromatic ring, together with the carbon atoms to which they are United; and the remaining symbols are defined in the description.
priorityDate 1995-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44284481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426340844

Total number of triples: 45.